Lymphoproliferative disorders in Oxford renal transplant recipients

Journal of Clinical Pathology

Volumn 56, Issue 6, 2003, Pages 439-446

  Bates, W D ^b   Gray, D W R ^a   Dada, M A ^c   Chetty, R ^c   Gatter, K C ^a   Davies, D R ^a   Morris, P J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DEMOGRAPHY; DISEASE COURSE; EUROPE; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; NORTH AMERICA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037972309     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.6.439     Document Type: Article

References (18)

1. Penn I, Hammond W, 8rettschneider L, et al. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-12.
2. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-16.
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
4. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology workshop. Semin Diagn Pathol 1997;14:8-14.
5. Liddington M, Richardson AJ, Higgins RM, et al. Skin cancer in renal transplant recipients. Br J Surg 1989;76:1002-5.
6. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41(11 Pt 1):4262-79.
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
8. Doak PB, Montgomerie JZ, North JD, et al. Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. BMJ 1968;4:746-8.
9. Schneck SA, Penn I. De-novo brain tumours in renal-transplant recipients. Lancet 1971;1:983-6.
10. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991;23(1 Pt 2):1101-3.
11. Sheil AG, Flavel S, Disney AP, et al. Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc 1985;17:1685-8.
12. Libertiny G, Watson CJ, Gray DW, et al. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001;88:1330-4.
13. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984;1:583-7.
14. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organisation classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86.
15. Gaya SB, Rees AJ, Lechler RI, et al. Malignant disease in patients with long-term renal transplants. Transplantation 1995;59:1705-9.
16. London NJ, Farmery SM, Will EJ, et al. Risk of neoplasia in renal transplant patients. Lancet 1995;346:403-6.
17. Margolius L, Stein M, Spencer D, et al. Kaposi's sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994;84:16-17.
18. Moosa MR, McBryne A. The development of malignancies in renal allograft recipients: the Tygerberg Hospital experience. S Afr J Surg 1997;35:156-64.